Controlled double-blind trial of camazepam, a new benzodiazepine derivative, versus chlordiazepoxide
- PMID: 27372
- DOI: 10.1007/BF00644605
Controlled double-blind trial of camazepam, a new benzodiazepine derivative, versus chlordiazepoxide
Abstract
31 in-patients with anxiety entered at random in a double-blind clinical trial of chlordiazepoxide and camazepam, a benzodiazepine derivative. They were assessed by three different rating scales. Statistical evaluation of the results showed similar psychopharmacological activity of both drugs. It is concluded that camazepam is suitable for treatment of mild and severe anxiety states.
Similar articles
-
[Double-blind test with a new benzodiazepine derivative (camazepam)].Med Monatsschr. 1976 Sep;30(9):413-5. Med Monatsschr. 1976. PMID: 10518 Clinical Trial. German. No abstract available.
-
Camazepam versus placebo. A double-blind clinical study on geriatric patients suffering from psychic complaints. Short Communication.Arzneimittelforschung. 1977;27(11):2177-8. Arzneimittelforschung. 1977. PMID: 23793 Clinical Trial.
-
A preliminary double-blind study with SB 5833 (camazepam), a new benzodiazepine derivative.Arzneimittelforschung. 1974 Dec;24(12):2032-5. Arzneimittelforschung. 1974. PMID: 4156178 Clinical Trial. No abstract available.
-
The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: half a century of anxiolytic drugs.J Anxiety Disord. 2011 May;25(4):554-62. doi: 10.1016/j.janxdis.2011.01.002. Epub 2011 Jan 22. J Anxiety Disord. 2011. PMID: 21315551 Review.
-
Benzodiazepines and neurotic anxiety. Critique.N Y State J Med. 1976 Dec;76(13):2156-64. N Y State J Med. 1976. PMID: 11427 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources